Evaluation of the effect of injectable dexamethasone on excretion of distal ureteral stones

Phase 3

Recruiting

• Conditions: Calculus of ureter.; Calculus of ureter; N20.1

• Registration Number: IRCT20200825048515N59
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 November 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Definitive diagnosis of distal ureteral stones below 1 cm
Age over 18 years
Indicated for drug therapy
Satisfaction to participate in the study

Exclusion Criteria

Having benign prostatic hyperplasia (BPH) at the same time
Having a narrowing of the urethra
Contraindications to the use of corticosteroids
Existence of hydronephrosis

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Frequent distal ureteral stone excretion. Timepoint: Until the end of two weeks of intervention. Method of measurement: Observational.;Time to excrete distal ureteral stone. Timepoint: Until the end of two weeks of intervention. Method of measurement: Observational.